These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16542523

  • 1. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M, Kirschner J, Herrmann J, Geth K, Korinthenberg R, Berweck S, Heinen F, Mall V.
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M.
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W, BaoQin G.
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW, Cole LL, Liptak GS.
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract] [Full Text] [Related]

  • 8. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK, Pedersen NR, Westphall IT, Pedersen LT, Jensen H, Villads A.
    Ugeskr Laeger; 2004 Aug 16; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy.
    Herrmann J, Mall V, Bigalke H, Geth K, Korinthenberg R, Heinen F.
    Neuropediatrics; 2000 Dec 16; 31(6):333-4. PubMed ID: 11508557
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI, Wasay M, Awan S.
    J Child Neurol; 2008 Dec 16; 23(12):1464-6. PubMed ID: 19073853
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu, Tiebin Yan, Jianning Mai.
    Clin Rehabil; 2009 Sep 16; 23(9):800-11. PubMed ID: 19482892
    [Abstract] [Full Text] [Related]

  • 15. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency.
    Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K.
    Eur J Paediatr Neurol; 2009 Sep 16; 13(5):421-9. PubMed ID: 18977158
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parent evaluation of spasticity treatment in cerebral palsy using botulinum toxin type A.
    Symons FJ, Rivard PF, Nugent AC, Tervo RC.
    Arch Phys Med Rehabil; 2006 Dec 16; 87(12):1658-60. PubMed ID: 17141650
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
    Scheinberg A, O'Flaherty S, Waugh MC, Baxter A, Gurd K.
    J Paediatr Child Health; 2008 Dec 16; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.